Delivery Order SPE2DX22D0010-SPE2D824FAJ82
- Not listed
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,770.93 contract is for the supply of ADZENYS XR-ODT 18.8 MG TABLET UD 30S, a pharmaceutical product, with a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $2,943.88 by the Defense Logistics Agency's Medical Supply Chain for the supply of ADZENYS XR ODT (orally disintegrating tablets) 6.3mg pharmaceutical product. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes firm fixed pricing under a competitive award with no set-aside designation. The place of performance is listed as the vendor's corporate office location in...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Adzenys XR ODT Tabs 12.5mg, a specialty medication, and has a ceiling value of $5,438.80. The contract is a firm fixed price delivery order with a completion date of May 5, 2023. This award is not associated with a specific set-aside program. AmerisourceBergen...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,362.28, is for the delivery of ADZENYS XR ODT TABS 1'S 12.5MG, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date is May 13, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
- This is a $1,642.02 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADZENYS XR-ODT 3.1 MG TABLET UD 30S, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025 and was awarded on January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Adzenys XR-ODT 18.8 mg tablets. The $1,362.90 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical division, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This is a $7,095.81 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADZENYS XR ODT TABS 1'S 18.8MG, a pharmaceutical product. The contract has an ultimate completion date of May 22, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADZENYS XR-ODT 18.8 MG TABLET UD 30S, a prescription medication, with a ceiling value of $1,333.80 and a completion date of June 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This federal contract award is for the delivery of ADZENYS XR ODT TABS 1'S 18.8MG, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $10,127.80 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of the pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop...
- This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADZENYS XR-ODT 9.4 MG TABLET UD 30S, a prescription medication, with a ceiling value of $2,212.51 and a performance period ending on June 27, 2025. The contract is not set-aside and was awarded on a firm-fixed-price basis. AmerisourceBergen Drug Corp holds a...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D824FAJ82Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,214.21 firm fixed-price contract is for the supply of ADZENYS XR ODT TABS, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999.00, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. AmerisourceBergen's parent company is Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 10/6/23 |